| Date | Time | Source | Headline | Symbol | Company |
| 07/20/2011 | 5:28PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 5:22PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 5:21PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 5:21PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 4:05PM | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 12:39PM | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 12:16PM | Business Wire | Harwood Feffer LLP Announces Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 10:37AM | Business Wire | Faruqi & Faruqi, LLP Announces Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 10:37AM | Business Wire | Kendall Law Group Investigates Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 8:01AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 7:54AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 7:52AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 7:49AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 7:48AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 7:47AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 7:46AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 7:00AM | Business Wire | AMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost Synergies | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/13/2011 | 4:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/01/2011 | 5:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/23/2011 | 4:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/23/2011 | 4:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/23/2011 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/23/2011 | 4:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/23/2011 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/23/2011 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/23/2011 | 4:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/20/2011 | 9:30AM | Zacks | Label Expansion for CELG's Istodax - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/17/2011 | 5:29PM | Business Wire | Data Shows Activity of FOLOTYN® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Following Treatment with ... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/17/2011 | 9:00AM | Marketwired | Research Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for Growth | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/17/2011 | 6:50AM | GlobeNewswire Inc. | Allos Therapeutics is MicroStockProfit.com's Biopharm Feature Stock | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |